Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
Holding TCRT?
Track your performance easily

Alaunos Therapeutics (TCRT) Ownership - Who Owns Alaunos Therapeutics?

670 Followers

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,692,403Insider605.30%26,751,032
4,001,856Institution249.92%11,045,123
1,799,280Insider112.37%4,966,013
744,145Insider46.47%2,053,840
608,648Institution38.01%1,679,868
398,050Insider24.86%1,098,618
372,120Insider23.24%1,027,051
255,027Institution15.93%703,875
224,282Insider14.01%619,018
207,434Insider12.95%572,518

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
608,648Institution38.01%1,679,868
255,027Institution15.93%703,875
110,297Institution6.89%304,420
100,850Institution6.30%278,346
49,363Institution3.08%136,242
8,180Institution0.51%22,577
7,309Institution0.46%20,173
267Institution0.02%737

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
40,392Institution2.52%149,854
20,471Institution1.28%75,947
1,056Institution0.07%2,978

FAQ

Who Owns Alaunos Therapeutics (TCRT)?
Currently, no data Available
What percentage of Alaunos Therapeutics (TCRT) stock is held by institutional investors?
Currently, no data Available
What percentage of Alaunos Therapeutics (TCRT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Alaunos Therapeutics (TCRT)?
Randal Kirk owns the most shares of Alaunos Therapeutics (TCRT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis